Cas:193813-85-3 5-(2-bromo-benzyl)-2h-tetrazole manufacturer & supplier

We serve Chemical Name:5-(2-bromo-benzyl)-2h-tetrazole CAS:193813-85-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-(2-bromo-benzyl)-2h-tetrazole

Chemical Name:5-(2-bromo-benzyl)-2h-tetrazole
CAS.NO:193813-85-3
Synonyms:5-(2-bromo-benzyl)-2h-tetrazole
Molecular Formula:C8H7BrN4
Molecular Weight:239.07200
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:54.46000
Exact Mass:237.98500
LogP:1.55300

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5-(2-bromo-benzyl)-2h-tetrazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-(2-bromo-benzyl)-2h-tetrazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-(2-bromo-benzyl)-2h-tetrazole Use and application,5-(2-bromo-benzyl)-2h-tetrazole technical grade,usp/ep/jp grade.


Related News: Fate Therapeutics has exclusively licensed from MSK foundational intellectual property covering the production and composition of iPSC-derived T cells. 5-(2-bromo-benzyl)-2h-tetrazole manufacturer With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout. 5-(2-bromo-benzyl)-2h-tetrazole supplier The memo denies the company made false statements to the FDA. In their complaint, employees said they were broadly concerned that quality control documents the FDA requires companies to maintain had been rewritten or fabricated. The employees did not specify whether these materials had been shown to the FDA. 5-(2-bromo-benzyl)-2h-tetrazole vendor Vietnam backtracked on Saturday and narrowed its restrictions to most flights from mainland China. 5-(2-bromo-benzyl)-2h-tetrazole factory Fate Therapeutics has exclusively licensed from MSK foundational intellectual property covering the production and composition of iPSC-derived T cells.